Charts and Graphics
- Figure 1.1: CME Department Organization: Centralized vs. Decentralized
- Figure 1.2: CME Departments' Reporting Relationships
- Figure 1.3: CME Staffing in FTEs by Company
- Figure 1.4: Average Percentage of Dedicated Staff Time Given to Media Mix
- Figure 1.5: CME Staffing Compared to Previous Year
- Figure 1.6: CME Staffing Projections for Coming Year
- Figure 1.7: Challenges to CME Program Management
- Figure 1.8: Yearly CME Budgets at Surveyed Companies
- Figure 1.9: Media Mix Spending: Budget Breakdown by Types of CME
- Figure 1.10: CME Budgets Compared to Previous Year
- Figure 1.11: CME Budget Projections for Coming Year
- Figure 2.1: Breakdown of how Companies Align their CME Activities
- Figure 2.2: Percent of CME Departments Receiving Input from Each Function
- Figure 2.3: Top Challenges Faced by Participating Pharmaceutical CME
Programs
- Figure 2.4: Effectiveness of Companies' CME Strategies
- Figure 2.5: Percent of Companies CME Strategy
- Figure 2.6: Percent of Companies Supporting CME by Continent
- Figure 4.1: Number of CME Events Sponsored Compared to Last Year
- Figure 4.2: Number of CME Events Supported by Surveyed Companies Annually
- Figure 4.3: CME Spending Per Event at Surveyed Companies
- Figure 4.4: Projections for Number of CME Events Sponsored in the Coming
Year
- Figure 4.5: Average Media Mix: Participation in Live vs. eCME Events
- Figure 4.6: Media Mix As a Percentage of Company Budget
- Figure 4.7: Media Mix as a Percentage of FTEs' Dedicated Time
- Figure 4.8: Top Challenges Faced by Participating Pharmaceutical CME
Programs
- Figure 5.1: CME Soft Goal Performance Measurement Process
- Figure 5.2: Percentage of Drug Companies that Track CME Return on
Investment (ROI)
- Figure 5.3: Companies' Self-Assessments of CME Events' Return on
Investment (ROI)
- Figure 6.1: Top Challenges Faced by Participating Pharmaceutical Companies
- Figure 6.2: US Sentencing Commission Guidelines
|
Related Report
|
View Cart
